StockData
Champions Oncology, Inc. logo

Champions Oncology, Inc. (CSBR) stock

CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 10/30245% above fair value
$4.59−0.09 (-1.89%)

Close on Nov 17, 2026Market cap $63.91MP/E –Yield –

Champions Oncology enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Champions Oncology's enterprise value was $62.74M on Nov 11, 2026, against $79.88M a year earlier. Over the last 5 years it ranged from $42.86M to $147.80M, with a median of $77.25M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$62.74M-28.3%
2025Dec 31, 2025$87.50M-23.7%
2024Dec 31, 2024$114.65M+61.7%
2023Dec 29, 2023$70.88M+40.9%
2022Dec 30, 2022$50.32M-53.4%
2021Dec 31, 2021$108.05M-20.4%
2020Dec 31, 2020$135.69M+44.3%
2019Dec 31, 2019$94.01M+7.2%
2018Dec 31, 2018$87.66M+108.8%
2017Dec 29, 2017$41.97M+79.2%
2016Dec 30, 2016$23.42M-13.0%
2015Dec 31, 2015$26.91M-18.1%
2014Dec 31, 2014$32.87M-6.9%
2013Dec 31, 2013$35.31M+331.1%
2012Dec 31, 2012$8.19M-56.3%
2011Dec 30, 2011$18.73M–

More Champions Oncology figures

See a number that looks wrong?